OpGen Inc (OPGN):企業の財務・戦略的SWOT分析

◆英語タイトル:OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH188486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

OpGen Inc (OPGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Dec 09,2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11,2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15,2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05,2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
OpGen Inc – Key Facts
OpGen Inc – Key Employees
OpGen Inc – Key Employee Biographies
OpGen Inc – Major Products and Services
OpGen Inc – History
OpGen Inc – Company Statement
OpGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
OpGen Inc – Business Description
Product Category: Collaboration Revenue
Overview
Performance
Product Category: Laboratory Services
Overview
Performance
Product Category: Product Sales
Overview
Performance
R&D Overview
OpGen Inc – SWOT Analysis
SWOT Analysis – Overview
OpGen Inc – Strengths
OpGen Inc – Weaknesses
OpGen Inc – Opportunities
OpGen Inc – Threats
OpGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud
Sep 30, 2020: OpGen announces award of German Government grant funding to its subsidiary Curetis and collaborators
Sep 16, 2020: Collaborative research by OpGen Group company ares genetics and Johns Hopkins researchers demonstrates potential of next-generation sequencing for investigation of genetic antimicrobial resistance mechanisms and molecular susceptibility testing
Aug 12, 2020: OpGen reports second quarter 2020 financial results and provides business update
Jul 15, 2020: OpGen provides business update and announces preliminary unaudited revenue and cash position for second quarter 2020
Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
OpGen Inc, Key Facts
OpGen Inc, Key Employees
OpGen Inc, Key Employee Biographies
OpGen Inc, Major Products and Services
OpGen Inc, History
OpGen Inc, Subsidiaries
OpGen Inc, Key Competitors
OpGen Inc, Ratios based on current share price
OpGen Inc, Annual Ratios
OpGen Inc, Annual Ratios (Cont...1)
OpGen Inc, Interim Ratios
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OpGen Inc (OPGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Ontario Power Generation Inc.:企業の戦略・SWOT・財務分析
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ONGC Videsh Ltd:企業の戦略的SWOT分析
    ONGC Videsh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Echo Therapeutics Inc (ECTE)-医療機器分野:企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • China Development Bank:企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務情報
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • I-Sens Inc (099190):製品パイプライン分析
    Summary I-Sens Inc (i-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise blood glucose monitoring systems, electrolyte and gas analyzers, immuno sensors and accessories, among others. It provides blood monitoring systems …
  • Fisia Italimpianti SpA:企業の戦略的SWOT分析
    Fisia Italimpianti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NIH Office of Technology Transfer-製薬・医療分野:企業M&A・提携分析
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • CRH plc:企業のM&A・事業提携・投資動向
    CRH plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CRH plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • CK Hutchison Holdings Ltd:企業の戦略・SWOT・財務情報
    CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hyatt Hotels Corporation:企業の戦略・SWOT・財務情報
    Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sutures India Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Sutures India Private Limited (SIPL) is a medical device company that manufactures and markets surgical sutures. The company provides absorbable sutures, surgical tape, surgical mesh, bone wax, nonabsorbable sutures, skin stapler and surgical gloves. Its absorbable sutures include plain catg …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • MDNA Life Sciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • Delta Electricity:企業の戦略的SWOT分析
    Delta Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆